Minerva Neurosciences (NERV) Net Income (2013 - 2026)

Minerva Neurosciences has reported Net Income for 14 years, with the latest figure at -$16.0 million in Q1 2026.

• For the quarter ending Q1 2026, Net Income fell 328.4% year-over-year to -$16.0 million; the trailing twelve-month figure through Mar 2026 stood at -$26.5 million (down 46.98% YoY), and the FY2025 full-year result was -$14.2 million, up 31.21% from the prior year.
• Net Income for Q1 2026 stood at -$16.0 million, down from -$4.4 million in the prior quarter.
• The five-year high for Net Income was -$2.7 million in Q3 2025, with the low at -$16.0 million in Q1 2026.
• Historically, Net Income has averaged -$5.7 million across 5 years, with a median of -$5.0 million in 2023.
• Annual changes were most pronounced in 2022 — Net Income surged 77.67% — and 2026, when it tumbled 328.4%.
• Minerva Neurosciences' Net Income stood at -$4.8 million in 2022, then slumped by 42.75% to -$6.8 million in 2023, then surged by 37.14% to -$4.3 million in 2024, then retreated by 3.56% to -$4.4 million in 2025, then tumbled by 261.71% to -$16.0 million in 2026.
• The last three Net Income figures came in at -$16.0 million (Q1 2026), -$4.4 million (Q4 2025), and -$2.7 million (Q3 2025), per Business Quant data.